Cycrin combined with Estradiol

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Female Other Serious 2/8/2000 Female 1/19/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/8/2000 Female 1/23/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/16/2001 54 Female 170 lb 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/16/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/21/2002 Female 3/1/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/21/2002 Female 3/6/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 1/30/2003 69 Female 3/20/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/24/2002 Female 5/1/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/24/2002 Female 4/25/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/24/2002 Female 4/28/2006 United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious 7/18/2003 55 Female 5/12/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/1998 59 Female 5/24/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/17/1998 59 Female 5/24/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/8/2001 Female 6/8/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/2/1998 Female 6/1/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/18/2003 55 Female 6/9/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/8/2002 Female 6/23/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/8/2002 Female 6/26/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/8/2002 Female 6/23/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/18/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 Female 7/20/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/18/2003 55 Female 7/19/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2000 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 74 Female 8/9/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 70 Female 8/9/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/28/2001 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/24/2002 Female 9/1/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/24/2002 Female 9/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2001 Female 12/29/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/1/2005 51 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 12/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/8/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2004 57 Female 10/10/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2001 Female 10/10/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 3/31/2004 65 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/24/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 Female 10/10/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 5/4/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/17/1999 68 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/1998 52 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/6/2000 66 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/24/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/23/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/7/2001 52 Female 188 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/30/2003 69 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 1/29/2007 Lawyer
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 1/29/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/22/2003 Female 3/8/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/22/2003 Female 3/16/2007 Lawyer United States
Primary
Secondary
Venous Insufficiency Other Serious 8/15/1999 54 Female 118 lb 3/17/2007
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/1999 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/21/2002 Female 12/22/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 11/19/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 55 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 60 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 55 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2004 68 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 4/24/2007 United States
Primary
Secondary
Concomitant
Radiotherapy Other Serious 4/22/1994 57 Female 135 lb 5/10/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Required Intervention Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Required Intervention 4/24/2002 Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2003 Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Required Intervention 1/1/2001 Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer In Situ Required Intervention 1/1/1998 59 Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/2/1998 Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary

Drug Data